UNI-EN 27:Current report 27 Notification
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 27 | / | 2015 | | ||||||
| Date of issue: | 2015-03-06 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 27 Notification | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of directors of Sopharma AD hereby notifies that as part of the process related to the merger of Bulgarian Rose – Sevtopolis AD into Sopharma AD the company has undertaken the registriton of the capital increase in the Central Depository AD. After communication with the Central Depository and with their kind assistance the calculation of the distribution of shares will be carried our under the provisions of the contract for merger signed between the two parties on June 19, 2014 and for the convenience of the shareholders for those that have more than one client account the calculaiton will be carried out baes on the total number of shares and the distribution between the different accounts will be carried our proportionally (the remainder will be distributed into the last account). We hereby notify that until the new issuance from the capital increase is registered into the public register of the Financial Supervision Commission the shares of Sopharma AD will be blocked and will not be traded. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 27 Notification.doc Current report 27 Notification.doc | Current report 27 Notification | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2015-03-06 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 5.75 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
